XBIT (XBiotech USA) Pangali Forward P/E
XBiotech Inc. (XBIT) develops antibodies to combat oncology using blood from healthy individuals. A narrow specialization in a single direction increases financial risks, as confirmed by the company's forward P/E NTM, where the value 0.00 represents the current figure. Research stability is ensured by a staff of high-caliber biologists operating on a unique technological base.
Ringkesan rincian data analitis XBiotech USA (XBIT)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal XBiotech Inc.|XBIT - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas XBiotech Inc.|XBIT - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku XBiotech Inc|XBIT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan XBiotech|Likuiditas cepet xbiotech.com
- rincian asil keuangan lan kelipatan valuasi:
XBIT - Penghasilan resik perusahaan|Bathi mangsa ngarep XBiotech Inc.|XBIT - Rasio rega pasar marang bathi resik|Pangali Forward P/E XBiotech Inc.|XBIT - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA XBiotech Inc|XBIT - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) XBiotech|XBIT - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan xbiotech.com|XBIT - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep XBiotech Inc.
Ringkesan analitik perusahaan:XBiotech
The forward P/E ratio determines the cost of one unit of projected earnings, allowing for an assessment of whether market capitalization is fair relative to future cash flows. For XBiotech Inc. (XBIT), analyzing the business's forward P/E is critical, as it filters out speculative noise surrounding clinical trial data and patent risks, revealing the asset's true fundamental value amidst volatile revenue.
Perusahaan pesaing
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Therapeutics)|aurabiosciences.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E CADL (Candel Therapeutics, Inc.)|Accuray Inc - Rega marang bathi mangsa ngarep|SELLAS Life Sciences Group Inc. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Actuate Therapeutics Inc ACTU|Citius Oncology, Inc. (CTOR) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi TuHURA Biosciences (HURA)|Prakiraan rega marang bathi TARA|FATE (Fate Therapeutics Inc) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E WHWK|TCRX - Rasio prakiraan rega marang bathi|Pangali Forward P/E CSBR (Champions Oncology, Inc.)|CVM - Prakiraan rega marang bathi|OS Therapies - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi RADX (radiopharmtheranostics.com)|ARTV (artivabio.com) - Prakiraan rega marang bathi|Adlai Nortye - Pangali mangsa ngarep rega marang bathi|VERU (Veru Inc.) - Pangali Forward P/E|tempesttx.com (TPST) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Xilio Therapeutics, Inc. (XLO)|renovarobio.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E MURA (Mural Oncology)|KAPA - Prakiraan rega marang bathi|OKUR: Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi CytoMed Therapeutics GDTC|CRIS (curis.com) - Prakiraan rega marang bathi|Rasio rega marang bathi mangsa ngarep APLM|THAR (Tharimmune Corp) - Pangali Forward P/E|Rega marang bathi mangsa ngarep ADVB|Pangali Forward P/E GNPX|Kapitalisasi marang proyeksi bathi calidibio.com|Sunshine Biopharma, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep XBIO (Xenetic Biosciences Inc.)|Salarius - Pangali Forward P/E|Kitov Pharma (PPBT) - Prakiraan rega marang bathi|AONC: Pangali Forward P/E|beigene.com (BGNE) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Checkpoint Therapeutics, Inc.|Rasio rega marang bathi mangsa ngarep ELEV (elevationoncology.com)|Pangali Forward P/E ICAD|Prakiraan rega marang bathi ikenaoncology.com IKNA|Pangali Forward P/E NTBL (Notable Labs, Ltd.)|Viracta Therapeutics Inc. (VIRX) - Rasio prakiraan rega marang bathi|MOR - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi NAYA (NAYA Biosciences Inc)|AAPGV (Ascentage Pharma Group Ltd) - Prakiraan rega marang bathi
